RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Baayenda, G., Mberu, M., Dodson, S., Zongo, K., Syonguvi, J., Ngondi, J., & Zecarias, A. (2025). Eritrea's blueprint for trachoma elimination: A home-grown model for sustainable impact. International Journal of Infectious Diseases, 152, 107814. Article 107814. https://doi.org/10.1016/j.ijid.2025.107814
Purpose: This overview highlights Eritrea's progress in trachoma elimination from 2006 to 2024, emphasizing the Surgery, Antibiotics, Facial Cleanliness and Environmental Improvement (SAFE) strategy, pillars of the Neglected Tropical Diseases (NTD) Roadmap, and geostatistical mapping's role in achieving elimination targets. Methods: Trachoma Impact Surveys (TIS) and Surveillance Surveys (TSS) monitored WHO-endorsed SAFE strategy interventions and progress, with model-based geo-statistics providing more precise prevalence estimates. Results: Eritrea has attained open defecation-free status in 93% of villages, performed 22,546 Trachomatous Trachiasis (TT) surgeries, and integrated surveillance data into the District Health Information System (DHIS2). TT prevalence among those 15 years and older has significantly decreased, with many areas below the World Health Organization (WHO) threshold of 0.2%. Eritrea reduced TF prevalence among children aged 1 to 9 years from over 10% in 2006 to less than 5% in 2022, and TT prevalence among adults aged 15 and older from 3% to below 0.2% in most regions. Conclusion: Eritrea's innovative approaches and strong partnerships provide a model for other countries facing NTDs. Reliable data have been crucial for targeting resources and monitoring progress toward trachoma elimination. (c) 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.